Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 20.95B 3.09B 2.72B 2.53B 2.32B 4.36B 298B 4.43B 30.02B 11.73B 147B 11.62B 11.37B 507B P/E 2026 *
14.1x
P/E 2027 * 12.2x
Enterprise Value 17.44B 2.58B 2.26B 2.1B 1.93B 3.63B 248B 3.68B 24.98B 9.76B 122B 9.67B 9.46B 422B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.51x
Free-Float
34.77%
Yield 2026 *
4.9%
Yield 2027 * 5.4%
1 day-1.55%
1 week-0.92%
Current month+22.42%
1 month+24.32%
3 months+1.15%
6 months-11.20%
Current year+4.43%
1 week 18.36
Extreme 18.36
19.49
1 month 14.39
Extreme 14.39
19.96
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 27/02/2019
Director of Finance/CFO 44 09/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 15/07/2013
Director/Board Member 63 07/08/2016
Chairman 48 27/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%-0.92%+7.04%-33.45% 3.09B
+1.57%-1.78%-22.79%-31.70% 15.05B
+1.91%+0.68%-19.33%-9.36% 5.91B
-1.00%+4.56%-10.88%-31.26% 3.9B
+2.03%+2.93%-28.79%-46.98% 3.22B
+0.71%-7.44%-41.90%-23.89% 2.96B
+1.72%+3.47%-13.21%+3.25% 2.63B
+2.56%-0.17%+96.84% - 2.56B
+1.82%-2.00%-41.24%-38.27% 1.51B
-0.67%-7.92%-4.51%+21.07% 1.51B
Average +0.92%-1.57%-7.88%-21.18% 4.23B
Weighted average by Cap. +1.14%-1.11%-13.00%-25.07%

Financials

2026 *2027 *
Net sales 29.91B 4.42B 3.88B 3.61B 3.31B 6.22B 425B 6.32B 42.84B 16.74B 209B 16.58B 16.22B 723B 33.03B 4.88B 4.28B 3.98B 3.66B 6.87B 470B 6.98B 47.32B 18.49B 231B 18.31B 17.92B 799B
Net income 1.48B 219M 193M 179M 164M 309M 21.11B 314M 2.13B 831M 10.38B 823M 805M 35.89B 1.71B 253M 222M 207M 190M 357M 24.38B 362M 2.46B 960M 11.99B 951M 930M 41.45B
Net Debt -3.52B -520M -456M -425M -390M -732M -50.05B -743M -5.04B -1.97B -24.61B -1.95B -1.91B -85.08B -4.01B -592M -520M -484M -444M -834M -57.03B -847M -5.74B -2.24B -28.04B -2.22B -2.18B -96.94B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
24/07/26 CN¥18.40 -1.55% 4,839,353
23/07/26 CN¥18.69 -0.37% 6,880,785
22/07/26 CN¥18.76 -0.79% 10,232,664
21/07/26 CN¥18.91 +0.48% 10,096,000
20/07/26 CN¥18.82 +1.35% 10,137,860
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.40CNY
Average target price
24.70CNY
Spread / Average Target
+34.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock